Annual SGA
$3.70 B
+$204.00 M+5.83%
December 31, 2024
Summary
- As of February 21, 2025, TEVA annual SGA is $3.70 billion, with the most recent change of +$204.00 million (+5.83%) on December 31, 2024.
- During the last 3 years, TEVA annual SGA has risen by +$174.00 million (+4.93%).
- TEVA annual SGA is now -30.40% below its all-time high of $5.32 billion, reached on December 31, 2013.
Performance
TEVA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$952.00 M
+$28.00 M+3.03%
December 31, 2024
Summary
- As of February 21, 2025, TEVA quarterly SGA is $952.00 million, with the most recent change of +$28.00 million (+3.03%) on December 31, 2024.
- Over the past year, TEVA quarterly SGA has stayed the same.
- TEVA quarterly SGA is now -34.25% below its all-time high of $1.45 billion, reached on December 31, 2013.
Performance
TEVA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$58.32 B
-$1.64 B-2.89%
December 31, 2024
Summary
- As of February 21, 2025, TEVA TTM SGA is -$58.32 billion, with the most recent change of -$1.64 billion (-2.89%) on December 31, 2024.
- Over the past year, TEVA TTM SGA has dropped by -$62.02 billion (-1675.82%).
- TEVA TTM SGA is now -197.30% below its all-time high of $59.94 billion.
Performance
TEVA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TEVA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.8% | 0.0% | -1675.8% |
| 3 y3 years | +4.9% | +5.0% | -1727.7% |
| 5 y5 years | -2.7% | -5.7% | -1688.3% |
TEVA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7.5% | at high | +15.8% | -37.5% | at low |
| 5 y | 5-year | -2.7% | +7.5% | -7.1% | +15.8% | -117.3% | at low |
| alltime | all time | -30.4% | >+9999.0% | -34.3% | +1934.2% | -197.3% | at low |
Teva Pharmaceutical Industries Limited Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $3.70 B(+5.8%) | $952.00 M(+3.0%) | $3.70 B(+1.4%) |
| Sep 2024 | - | $924.00 M(-1.6%) | $3.65 B(+2.2%) |
| Jun 2024 | - | $939.00 M(+6.0%) | $3.57 B(+0.8%) |
| Mar 2024 | - | $886.00 M(-1.8%) | $3.54 B(+1.3%) |
| Dec 2023 | $3.50 B(+1.5%) | $902.00 M(+6.9%) | $3.50 B(+1.9%) |
| Sep 2023 | - | $844.00 M(-7.3%) | $3.43 B(+0.6%) |
| Jun 2023 | - | $910.00 M(+8.1%) | $3.41 B(+0.1%) |
| Mar 2023 | - | $842.00 M(+0.6%) | $3.41 B(-1.1%) |
| Dec 2022 | $3.44 B(-2.4%) | $837.00 M(+1.8%) | $3.45 B(-2.0%) |
| Sep 2022 | - | $822.00 M(-9.4%) | $3.52 B(-1.8%) |
| Jun 2022 | - | $907.00 M(+3.1%) | $3.58 B(+1.4%) |
| Mar 2022 | - | $880.00 M(-3.1%) | $3.53 B(+0.1%) |
| Dec 2021 | $3.53 B(-3.9%) | $908.00 M(+2.3%) | $3.53 B(-2.8%) |
| Sep 2021 | - | $888.00 M(+3.6%) | $3.63 B(+0.1%) |
| Jun 2021 | - | $857.00 M(-2.1%) | $3.63 B(-0.1%) |
| Mar 2021 | - | $875.00 M(-13.4%) | $3.63 B(-1.1%) |
| Dec 2020 | $3.67 B(-3.5%) | $1.01 B(+14.3%) | $3.67 B(-0.4%) |
| Sep 2020 | - | $884.00 M(+2.7%) | $3.69 B(+0.1%) |
| Jun 2020 | - | $861.00 M(-6.1%) | $3.68 B(-2.7%) |
| Mar 2020 | - | $917.00 M(-10.5%) | $3.78 B(-0.6%) |
| Dec 2019 | $3.81 B(-9.7%) | $1.02 B(+16.5%) | $3.81 B(-3.0%) |
| Sep 2019 | - | $880.00 M(-8.5%) | $3.92 B(-3.2%) |
| Jun 2019 | - | $962.00 M(+2.3%) | $4.05 B(-0.9%) |
| Mar 2019 | - | $940.00 M(-17.6%) | $4.09 B(-3.0%) |
| Dec 2018 | $4.21 B(-13.0%) | $1.14 B(+13.2%) | $4.21 B(+3.5%) |
| Sep 2018 | - | $1.01 B(+1.0%) | $4.07 B(-4.8%) |
| Jun 2018 | - | $998.00 M(-6.5%) | $4.28 B(-6.7%) |
| Mar 2018 | - | $1.07 B(+6.7%) | $4.59 B(-5.3%) |
| Dec 2017 | $4.85 B(-2.6%) | $1.00 B(-17.7%) | $4.85 B(-6.1%) |
| Sep 2017 | - | $1.22 B(-7.0%) | $5.16 B(-0.7%) |
| Jun 2017 | - | $1.31 B(-1.3%) | $5.20 B(+0.9%) |
| Mar 2017 | - | $1.32 B(+0.5%) | $5.15 B(+3.6%) |
| Dec 2016 | $4.97 B(+2.8%) | $1.32 B(+5.4%) | $4.97 B(-0.2%) |
| Sep 2016 | - | $1.25 B(-1.0%) | $4.98 B(+3.2%) |
| Jun 2016 | - | $1.26 B(+10.5%) | $4.83 B(+1.6%) |
| Mar 2016 | - | $1.14 B(-13.9%) | $4.75 B(-1.8%) |
| Dec 2015 | $4.84 B(-4.7%) | $1.33 B(+21.2%) | $4.84 B(+0.0%) |
| Sep 2015 | - | $1.10 B(-7.5%) | $4.84 B(-3.0%) |
| Jun 2015 | - | $1.19 B(-3.6%) | $4.98 B(-0.8%) |
| Mar 2015 | - | $1.23 B(-7.3%) | $5.02 B(-1.1%) |
| Dec 2014 | $5.08 B(-4.5%) | $1.33 B(+6.7%) | $5.08 B(-2.3%) |
| Sep 2014 | - | $1.24 B(+1.6%) | $5.20 B(-0.5%) |
| Jun 2014 | - | $1.22 B(-4.9%) | $5.22 B(-1.5%) |
| Mar 2014 | - | $1.29 B(-11.2%) | $5.30 B(-0.3%) |
| Dec 2013 | $5.32 B(+3.9%) | $1.45 B(+14.2%) | $5.32 B(+1.4%) |
| Sep 2013 | - | $1.27 B(-2.5%) | $5.25 B(+1.2%) |
| Jun 2013 | - | $1.30 B(-0.1%) | $5.18 B(+0.1%) |
| Mar 2013 | - | $1.30 B(-5.2%) | $5.18 B(+1.2%) |
| Dec 2012 | $5.12 B(+16.0%) | $1.37 B(+13.9%) | $5.12 B(+0.5%) |
| Sep 2012 | - | $1.21 B(-7.0%) | $5.09 B(+6.0%) |
| Jun 2012 | - | $1.30 B(+4.6%) | $4.81 B(+4.5%) |
| Mar 2012 | - | $1.24 B(-8.2%) | $4.60 B(+4.2%) |
| Dec 2011 | $4.41 B(+15.1%) | $1.35 B(+47.2%) | $4.41 B(+6.6%) |
| Sep 2011 | - | $918.00 M(-15.6%) | $4.14 B(-1.6%) |
| Jun 2011 | - | $1.09 B(+3.3%) | $4.21 B(+6.5%) |
| Mar 2011 | - | $1.05 B(-2.4%) | $3.95 B(+3.1%) |
| Dec 2010 | $3.83 B(+9.5%) | $1.08 B(+9.3%) | $3.83 B(+2.9%) |
| Sep 2010 | - | $987.00 M(+18.5%) | $3.72 B(+2.9%) |
| Jun 2010 | - | $833.00 M(-10.8%) | $3.62 B(-0.4%) |
| Mar 2010 | - | $934.00 M(-3.7%) | $3.63 B(+3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $3.50 B(+39.3%) | $970.00 M(+9.9%) | $3.50 B(+9.0%) |
| Sep 2009 | - | $883.00 M(+4.4%) | $3.21 B(+7.9%) |
| Jun 2009 | - | $846.00 M(+5.8%) | $2.97 B(+6.3%) |
| Mar 2009 | - | $800.00 M(+17.6%) | $2.80 B(+11.4%) |
| Dec 2008 | $2.51 B(+32.1%) | $680.00 M(+4.9%) | $2.51 B(+6.9%) |
| Sep 2008 | - | $648.00 M(-3.1%) | $2.35 B(+8.8%) |
| Jun 2008 | - | $669.00 M(+30.2%) | $2.16 B(+10.2%) |
| Mar 2008 | - | $514.00 M(-0.8%) | $1.96 B(+3.1%) |
| Dec 2007 | $1.90 B(+20.9%) | $518.00 M(+13.1%) | $1.90 B(+2.2%) |
| Sep 2007 | - | $458.00 M(-2.3%) | $1.86 B(+3.0%) |
| Jun 2007 | - | $469.00 M(+2.9%) | $1.81 B(+5.5%) |
| Mar 2007 | - | $456.00 M(-4.4%) | $1.71 B(+8.9%) |
| Dec 2006 | $1.57 B(+96.7%) | $477.10 M(+18.2%) | $1.57 B(+19.8%) |
| Sep 2006 | - | $403.80 M(+7.5%) | $1.31 B(+16.9%) |
| Jun 2006 | - | $375.50 M(+18.8%) | $1.12 B(+20.7%) |
| Mar 2006 | - | $316.00 M(+45.2%) | $930.40 M(+16.4%) |
| Dec 2005 | $799.00 M(+14.6%) | $217.70 M(+1.7%) | $799.00 M(+3.8%) |
| Sep 2005 | - | $214.00 M(+17.1%) | $769.70 M(+4.4%) |
| Jun 2005 | - | $182.70 M(-1.0%) | $737.20 M(+1.9%) |
| Mar 2005 | - | $184.60 M(-2.0%) | $723.50 M(+3.8%) |
| Dec 2004 | $697.00 M(+33.9%) | $188.40 M(+3.8%) | $697.00 M(+7.0%) |
| Sep 2004 | - | $181.50 M(+7.4%) | $651.30 M(+9.4%) |
| Jun 2004 | - | $169.00 M(+6.9%) | $595.10 M(+7.0%) |
| Mar 2004 | - | $158.10 M(+10.8%) | $556.00 M(+6.8%) |
| Dec 2003 | $520.60 M(+28.1%) | $142.70 M(+13.9%) | $520.60 M(+8.0%) |
| Sep 2003 | - | $125.30 M(-3.5%) | $482.00 M(+3.6%) |
| Jun 2003 | - | $129.90 M(+5.9%) | $465.10 M(+7.2%) |
| Mar 2003 | - | $122.70 M(+17.9%) | $433.90 M(+6.8%) |
| Dec 2002 | $406.40 M(+11.8%) | $104.10 M(-4.0%) | $406.40 M(+1.4%) |
| Sep 2002 | - | $108.40 M(+9.8%) | $400.86 M(+6.4%) |
| Jun 2002 | - | $98.70 M(+3.7%) | $376.66 M(+2.1%) |
| Mar 2002 | - | $95.20 M(-3.4%) | $368.74 M(+1.4%) |
| Dec 2001 | $363.56 M(+18.4%) | $98.56 M(+17.1%) | $363.60 M(+1.3%) |
| Sep 2001 | - | $84.20 M(-7.2%) | $359.04 M(+1.7%) |
| Jun 2001 | - | $90.78 M(+0.8%) | $353.11 M(+5.3%) |
| Mar 2001 | - | $90.06 M(-4.2%) | $335.48 M(+9.2%) |
| Dec 2000 | $307.08 M(+31.3%) | $94.00 M(+20.1%) | $307.08 M(+8.8%) |
| Sep 2000 | - | $78.27 M(+7.0%) | $282.27 M(+8.1%) |
| Jun 2000 | - | $73.14 M(+18.6%) | $261.20 M(+7.6%) |
| Mar 2000 | - | $61.66 M(-10.9%) | $242.85 M(+3.8%) |
| Dec 1999 | $233.89 M(+12.4%) | $69.19 M(+21.0%) | $233.89 M(+6.4%) |
| Sep 1999 | - | $57.20 M(+4.4%) | $219.80 M(-0.0%) |
| Jun 1999 | - | $54.80 M(+4.0%) | $219.90 M(+2.8%) |
| Mar 1999 | - | $52.70 M(-4.4%) | $214.00 M(+2.8%) |
| Dec 1998 | $208.00 M(+5.6%) | $55.10 M(-3.8%) | $208.10 M(+36.0%) |
| Sep 1998 | - | $57.30 M(+17.2%) | $153.00 M(+59.9%) |
| Jun 1998 | - | $48.90 M(+4.5%) | $95.70 M(+104.5%) |
| Mar 1998 | - | $46.80 M | $46.80 M |
| Dec 1997 | $197.00 M(+17.5%) | - | - |
| Dec 1996 | $167.60 M(+15.3%) | - | - |
| Dec 1995 | $145.40 M(+12.1%) | - | - |
| Dec 1994 | $129.70 M(+28.2%) | - | - |
| Dec 1993 | $101.20 M(+22.7%) | - | - |
| Dec 1992 | $82.50 M(+23.0%) | - | - |
| Dec 1991 | $67.10 M(-20.9%) | - | - |
| Dec 1990 | $84.80 M(+51.2%) | - | - |
| Dec 1989 | $56.10 M(+9.4%) | - | - |
| Dec 1988 | $51.30 M(+69.3%) | - | - |
| Mar 1987 | $30.30 M(+78.2%) | - | - |
| Mar 1986 | $17.00 M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual SGA?
- What is the all time high annual SGA for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual SGA year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly SGA?
- What is the all time high quarterly SGA for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly SGA year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM SGA?
- What is the all time high TTM SGA for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM SGA year-on-year change?
What is Teva Pharmaceutical Industries Limited annual SGA?
The current annual SGA of TEVA is $3.70 B
What is the all time high annual SGA for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual SGA is $5.32 B
What is Teva Pharmaceutical Industries Limited annual SGA year-on-year change?
Over the past year, TEVA annual SGA has changed by +$204.00 M (+5.83%)
What is Teva Pharmaceutical Industries Limited quarterly SGA?
The current quarterly SGA of TEVA is $952.00 M
What is the all time high quarterly SGA for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly SGA is $1.45 B
What is Teva Pharmaceutical Industries Limited quarterly SGA year-on-year change?
Over the past year, TEVA quarterly SGA has changed by $0.00 (0.00%)
What is Teva Pharmaceutical Industries Limited TTM SGA?
The current TTM SGA of TEVA is -$58.32 B
What is the all time high TTM SGA for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM SGA is $59.94 B
What is Teva Pharmaceutical Industries Limited TTM SGA year-on-year change?
Over the past year, TEVA TTM SGA has changed by -$62.02 B (-1675.82%)